Clinical Trials List
2007-05-01 - 2008-03-31
Phase III
Terminated6
-
Trial Applicant
PROTECH PHARMASERVICES CORPORATION
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 曾炳憲 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 張其任 Division of Cardiovascular Diseases
- Pao-Hsien Chu Division of Cardiovascular Diseases
- 王俊力 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Juey-Jen Hwang Division of Cardiovascular Diseases
- CHIA-TI TSAI Division of Cardiovascular Diseases
- 賴凌平 Division of Cardiovascular Diseases
- Yi-Chih Wang Division of Cardiovascular Diseases
- 許寬立 Division of Cardiovascular Diseases
- - - Division of Cardiovascular Diseases
- 江福田 Division of Cardiovascular Diseases
- JYH-MING JIMMY JUANG Division of Cardiovascular Diseases
- LIAN-YU LIN Division of Cardiovascular Diseases
- Jin-Jer Chen Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Hsin Hsu Division of General Internal Medicine
- Ju-Yi Chen Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳志成 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
184 participants
-
Global
0 participants
